Resistant Hypertension in Chronic Kidney Disease
312 to prevent the thrombus formation and endothelium damage during RF RDN at the ablation site. Furthermore, given the adventit ...
313 were racial differences in antihypertensive RDN effects. In a group of non-African- Americans, office systolic blood pressur ...
314 and DBP of 17 mmHg 3 months after RDN done with this system. In the TIVUS (therapeutic intravascular ultrasound) system, the ...
315 assessed by serum creatinine and cystatin C concentrations or eGFR was preserved during 1 year follow-up. Nevertheless in so ...
316 Table 19.2 Clinical studies on interventional treatments of resistant hypertension in chronic kidney disease patients Hering ...
317 stimulating nociceptive afferent SNS. There is also a case report describing the ADPKD patient in whom RDN leads to immedia ...
318 arterial pressure and reduced plasma norepinephrine concentration. Assessment of acute electric baroreflex activation was do ...
319 Baroreflex Activation Therapy in CKD Based on the pathophysiological evidence described above (i.e., SNS overactivity and th ...
320 References Converse RL Jr, Jacobsen TN, Toto RD, Jost CM, Cosentino F, Fouad-Tarazi F, Victor RG. Sympathetic overactivity ...
321 Ott C, Mahfoud F, Schmid A, Toennes SW, Ewen S, Ditting T, Veelken R, Ukena C, Uder M, Böhm M, Schmieder RE. Renal denervat ...
© Springer International Publishing AG 2017 323 A. Covic et al. (eds.), Resistant Hypertension in Chronic Kidney Disease, DOI 10 ...
324 Study [ 7 ], patients with moderate-to-severe OSAS were found to have 3.2-fold increased odds of developing HT relative to s ...
325 Patients with OSAS were also found to have increased plasma angiotensin II levels. Moreover, treatment of OSAS with CPAP sig ...
326 the CPAP group. These positive findings were only observed in patients who used CPAP more than 5.8 h [ 41 ]. In the study by ...
327 patients are adherent to CPAP treatment, BP control could not be established in nearly 30% of patients using CPAP treatment ...
328 Possible Mechanisms of Action of CPAP Treatment on Blood Pressure Control Mechanism of action of CPAP on the treatment of HT ...
329 Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep- disordered breathing and hyper ...
330 Gaddam K, Pimenta E, Thomas SJ, et al. Spironolactone reduces severity of obstructive sleep apnoea in patients with resista ...
331 Pedrosa RP, Drager LF, de Paula LK, Amaro AC, Bortolotto LA, Lorenzi-Filho G. Effects of OSA treatment on BP in patients wi ...
332 Montesi SB, Edwards BA, Malhotra A, Bakker JP. The effect of continuous positive airway pressure treatment on blood pressur ...
«
10
11
12
13
14
15
16
17
18
19
»
Free download pdf